Collegium Pharmaceutical (COLL) Amortization of Deferred Charges (2014 - 2026)

Collegium Pharmaceutical's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $819000.0 for Q1 2026.

• In Q1 2026, Amortization of Deferred Charges fell 40.09% year-over-year to $819000.0; the TTM figure through Mar 2026 stood at $4.3 million (down 15.53% YoY), while the FY2025 annual figure was $5.3 million, down 11.22% from the prior year.
• Amortization of Deferred Charges was $819000.0 for Q1 2026 at Collegium Pharmaceutical, down from $1.3 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $2.5 million in Q2 2022 to a low of $819000.0 in Q1 2026.
• Historically, Amortization of Deferred Charges has averaged $1.6 million across 5 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges jumped 205.91% in 2022, then plunged 48.0% in 2024.
• A 5-year view of Amortization of Deferred Charges shows it stood at $2.4 million in 2022, then dropped by 17.62% to $2.0 million in 2023, then declined by 27.46% to $1.4 million in 2024, then declined by 10.39% to $1.3 million in 2025, then slumped by 35.82% to $819000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $819000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.